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Abstract The differential diagnosis between Alzheimer’s disease (AD) and major depression (MD) in the 
elderly can be problematic because the cognitive profile of the two conditions overlaps. Associative 
learning tasks seem to separate AD from MD. However, they are sensitive to the effects of normal 
ageing. Short-term memory-binding tasks have proved insensitive to the effects of normal ageing and 
highly sensitive to AD. However, they have not been used to differentiate AD from MD. The present 
study was aimed at investigating visual short-term memory binding in AD and MD. Fourteen AD 
patients, 14 patients with MD, and 14 healthy older adults were asked to perform a visual short-term 
memory binding task that investigated the retention of shapes, colors, or combinations of shapes and 
colors. Participants were to recognize changes occurring between two consecutive displays either in a 
single dimension (i.e., shape or color only) or in two dimensions (i.e., shape-color binding). Short-term 
memory performance for shape or color only was equivalent across groups. The only significant effect 
found was in short-term memory for shape-color binding and this was due to AD patients performing 
poorly in this condition only. The results extend previous findings in AD to visual short-term memory 
and suggest that the specific impairment in binding information in memory differentiates between the 
performance of AD and patients with MD. 
 
Keywords Alzheimer’s disease, major depression, short-term memory, memory binding, working 
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Introduction 
The differential diagnosis between early Alzheimer’s disease (AD) and major depression (MD) in the   
elderly can be problematic [4, 16, 22, 71, 79]. MD can precede AD and occur in the early stages of the 
disease [9, 30, 34, 35, 39, 42]. Moreover, the neuropsychological tasks currently used to assess AD are 
performed poorly by patients with MD (e.g., memory, attention, and executive functions) [2, 13, 37, 75]. 
Therefore, more specific methods are required to differentiate between the two conditions. Poor 
performance on episodic memory tasks have long been thought to characterize AD [17, 70]. However, 
memory dysfunction appears to occur in both AD and MD [2, 3, 9, 30, 34, 35, 39, 42, 46, 75, 88], 
suggesting that tests of episodic memory might be sensitive but not specific to AD. As a result, several 
memory tests and batteries of tests have been proposed to disentangle the two conditions 
[16, 17, 28, 41, 51, 88]. However, none of these measures appear to combine sensitivity with specificity 
for AD when subjected to rigorous testing [24, 28, 45].               
   
 Paired associate learning tasks have been reported to be particularly sensitive to AD and much less so to 
MD [5, 16, 25, 79]. Swainson et al. [79] reported that performance on the Paired Associates Leaning Task 
of the Cambridge Neuropsychological Test Automated Battery (PAL-CANTAB), a cued recall task that 
assesses the learning of object-location associations, resulted in 7% of overlap between AD patients and 
healthy controls/depressed patients (the scores of the last two groups were collapsed for such 
comparisons). In contrast, the Warrington SRMT with words and faces, showed overlaps of 99 and 78%, 
respectively. Dierckx et al. [16] used the visual association test (VAT) [47] and the memory impairment 
screen (MIS) [10] to produce a combined VAT-MIS score and compared performance of AD, MD, and 
mild cognitive impairment (MCI) patients. The combined score yielded a sensitivity of 83% (58%) and a 
specificity of 85% (85%) for differentiating AD (MCI) from MD.     
Are such cued recall tasks that assess associative learning the solution for the early detection of AD and 
its differential diagnosis from depression? To answer this question, we would like to address some caveats 
regarding the studies discussed above. Firstly, the PAL-CANTAB task used by Swainson et al. [79] does 
not separate the contribution of item memory and associative memory from the deficits in recalling 
complex events. There is evidence suggesting that AD affects visuo-spatial memory [36, 57, 74] and 
particularly memory for item locations [7, 43, 77]. Hence, the PAL-CANTAB task does not assess the 
extent to which these object-location associative memory deficits can be accounted for by deficits in 
recalling locations only. Secondly, there are two issues concerning the methodological approach used by 
Swainson et al. [79] which may prevent a clear-cut assessment of their hypotheses. In their analysis the 
authors merged depressed and control participants in one single group and compared this to AD patients. 
Hence it is unclear how many depressed patients were actually better than the AD patients. Moreover, 
this may have resulted in dramatically low overlapping values because the size of the to-be-compared 
group was increased by including participants that were completely healthy. The results of the 
neuropsychological assessment shown by Swainson et al. [79] also revealed dramatic differences between 
depressed patients and controls in tasks such as logical memory (30 min recall), doors recognition, pattern 
recognition, category fluency, and others. Therefore, the actual contribution of the PAL-CANTAB task 
to the differential diagnosis of AD and depression cannot be clearly maintained from this study. Thirdly, 
in the paper by Dierckx et al. [16] no information on the neuropsychological assessment of depressed 
patients was presented. Hence, it is difficult to determine the actual contribution of the combined VAT-
MIS score relative to other more traditional tasks.      
Furthermore, the results reported by Dierckx et al. [16] are complicated by the fact that the depressed 
patients included in the study (but not the AD patients) were under treatment with antidepressants, which 
are known to improve performance on hippocampal-related tasks such as cued recall [38]. Lastly, the 
tasks reported by these authors [16, 79] assess associative learning, a function that has proved to be 
affected in normal ageing [12, 15, 58–63].       
Recently it has been demonstrated that a different associative memory task, namely, short-term memory 
(STM) binding has been found to be substantially impaired in AD. Verbal STM-binding deficits were 
reported in patients with late-onset sporadic AD [67]. Contrary to associative learning, binding 
information in visual STM has been found to be preserved in normal ageing [8, 68]. This represents a step 
forward in the assessment of age-related disorders, as other forms of STM and LTM binding have been 
found to be impaired in older adults [14, 59, 62, 63]. In particular, the specific requirement of binding 
items to their spatial locations seems to make memory-binding tasks more sensitive to the effect of 
normal ageing [14, 55, 56].         
Research on visual memory binding suggests that the efficiency of the mechanisms responsible for 
representing these complex events in memory may be sensitive to age [63], brain pathology [66, 67], and 
to methodological manipulations in experiments involving healthy young participants (e.g., type and 
amount of information, retention interval, availability of long-term representations, etc.) [1, 48, 86]. For 
example, holding in visual STM a “blue apple” and a “pink book” is a task efficiently performed by older 
people [67]. However, holding in visual STM an “apple on a TV” and a “book on a refrigerator” may be 
an extremely difficult task for older adults (see [56]). Retaining in visual STM “shapes only” or “colored 
shapes” results in no behavioral difference in healthy young or older participants [8, 29]. However, 
retaining in visual STM “unicolored objects” or “bicolored objects” results in a dramatic drop in 
performance in the latter task regardless of age [68]. One common mechanism underlying successful 
performance in these tasks is the requirement of linking (i.e., binding) different features across different 
dimensions (i.e., color, shape, or location) or visual streams (i.e., ventral or dorsal). It might be possible 
that the differences observed across studies arise from the different demands of these tasks to develop 
effective connectivity across or within these feature dimensions [31, 33, 64].   
Nevertheless, we have consistently found that the STM-binding functions investigated here are not 
differentially impaired in normal ageing. This allows us to reliably use these tasks to assess STM-binding 
in age-related disorders such as AD and MD. In fact, visual STM binding has not been previously used to 
assess patients with late-onset sporadic AD and neither has visual STM binding been used to discriminate 
between AD and MD in the elderly. This study was aimed at investigating visual STM binding in AD and 
MD. 
Methods 
Participants 
Three groups of participants were recruited for the study. One group consisted of 14 patients with AD 
diagnosed according to the criteria established by the DSM-IV-TR and the NINCDS-ADRDA [53]. A 
second group consisted of 14 patients diagnosed with chronic depression (mean global depression scale 
score = 16.4, SD = 5.9; mean depression duration (from time of initial contact with services about 
depression to testing) = 11.3 years, SD = 9.11) according to the criteria established by the DSM-IV-TR. 
The third group involved 14 healthy older adults. Patients were referred by old age consultants. Healthy 
older adults were recruited through the panel of volunteers of the Psychology Department of the 
University of Edinburgh. All participants gave their informed consent to take part in the study. The study 
was approved by the relevant ethics committees.       
 The inclusion criteria set for the study were: (1) Normal color vision as assessed by the color 
blindness test [18]. (2) No other neurological or psychiatric disorders. (3) Score above 14 for the AD 
patients in the mini mental state examination (MMSE) [23]. (4) When possible, a brain CT or MRI scan 
ruling out cerebrovascular diseases. (5) Depressed patients were not taking tricyclic antidepressants. (6) 
Normal perceptual binding functions as assessed by the task described below. An additional inclusion 
criterion for the AD patients was (7) no history of chronic depression and no antidepressant medication 
at the time of assessment.        
 Perception for shape-color binding was assessed with a task that simultaneously presented two 
arrays of four colored shapes each, one in the upper half of the screen and one in the lower half. On each 
of the 20 trials, participants searched for changes between the two arrays. The arrays and the changes 
were the same as those described below for the shape-color binding condition. Participants with visual 
search accuracy below 90% (18 out of 20 trials correct) were not assessed further. None of the patients or 
healthy older adults recruited for the study was excluded due to perceptual binding problems. 
 The three groups of participants were matched according to age, gender distribution, and the 
number of years spent in formal education. Additionally, healthy older adults and depressed patients were 
matched according to their MMSE scores. The demographic and psychometric characteristics of the three 
groups of participants are shown in Table 1. 
Assessment 
The assessment consisted of two parts, a Neuropsychological Battery and a visual STM Task. The 
Neuropsychological Battery comprised the Addenbrooke’s Cognitive Examination [54] which 
incorporates the Mini Mental State Examination, Recall and Recognition of Word Lists [85], Letter (FAS) 
Fluency, Trail Making Test Parts A and B [72], The Complex Figure of Rey-Osterrieth Copy and Delayed 
Recall [65, 73].           
 The visual STM task presented visual arrays of two or three stimuli each on a 15-in. flat TFT 
screen controlled by a laptop personal computer. Stimuli for each array were randomly selected from one 
set of eight shapes and one set of eight colors (see Fig. 1a for the set of shapes used). At the beginning of 
each trial, a fixation screen was presented for 500 ms. This was followed by the study display presented 
for 2,000 ms. After a blank retention interval of 900 ms, the test display was presented. On 50% of trials, 
the study and test displays were identical. On the other 50%, there were changes between the study and 
test display. The task for the participant was to detect when a change had occurred and to respond orally 
‘same’ or ‘different’ as appropriate. Items randomly changed locations between trials, and were shown in 
different random locations for study and test arrays. This rendered location an irrelevant feature to the 
task, so location could not be used as a memory cue. The experimenter entered participants’ responses 
using the keyboard. There was then a gap of 1,000 ms until the next trial (see Fig. 1b).  
 The STM task consisted of three conditions. Two conditions assessed visual STM for single 
features and one assessed the binding of these features in visual STM. In the Shape only and Color only 
conditions, the study arrays consisted of black shapes or colors (Fig. 1b). In the test display for the 
different trials, two new shapes or new colors from the study array were replaced by new shapes or new 
colors. In the Shape-color binding condition, the arrays consisted of combinations of shapes and colors. 
In the test display for the different trials, two shapes swapped the colors in which they had been shown in 
the study display. Hence, memory for bindings of shape and color in the study display was required in 
order to detect this change. In none of the three conditions were features repeated within a given array. 
For each condition there were 15 practice trials followed by 32 test trials. Trials were fully randomized 
across participants and conditions were blocked and delivered in a counterbalanced order. All the 
participants performed the visual STM task described above. Figure 1b shows an example trial for each 
experimental condition. 
Statistical analysis  
The array sizes used in the task for all participants were two and three items. However, post-hoc analyses 
suggested that performance levels in memory for single features would be similar across groups and floor 
and ceiling effects would be avoided when comparing AD patients with two items and MD patients and 
controls with three items. This follows our standard procedures (e.g., [49, 50, 67]) for comparing the 
impact of experimental manipulations on patients and controls. Reducing group differences in conditions 
assessing memory for single features, which provided baseline performance for investigating binding, 
would determine whether any differences between groups on STM-binding performance could be 
attributed to the binding requirement and not to baseline differences in memory for single features. In 
other words, this would rule out poor performance in the binding condition due to increased memory 
load. Therefore, AD patient’s performance with only two items and controls’ and depressed patients’ 
performance with only three items were analyzed further (performance of the three groups with the two 
set sizes can be found in Supplementary Material).      
 Initial ANOVA and Chi-square analyses revealed that age and gender distributions did not differ 
across groups. Further, ANCOVA with age and gender as covariates showed that these factors did not 
modify the main outcomes nor did they interact with other independent variables (i.e., Group or 
Condition). Therefore, these factors were not further considered in statistical analyses. Subsequent two-
way mixed ANOVA was performed. The between-subjects factor was Group (healthy older adults vs. 
depressed patients vs. AD patients) and the within-subjects factor was Condition (shape only vs. color 
only vs. shape-color binding). To assess significant interactions, post-hoc comparisons were carried out 
across groups for each condition separately (3 × 3 = 9 contrasts) and across conditions for each group 
separately (3 × 3 = 9 contrasts). With a total of 18 pairwise comparisons, the Bonferroni corrected alpha 
level was set at 0.003. Two measures of the signal detection theory were calculated for the analysis [76]. 
Sensitivity for the change detection (A′) and response bias (Beta) were entered as the dependent variables.
 Finally, ROC analysis was carried out to investigate the accuracy with which the STM task 
presented here can detect AD and differentiate this condition from MD. In doing so, we calculated the 
sensitivity, specificity, and positive and negative predictive values for each score of the STM task. 
Results 
Neuropsychological assessment 
The analysis of the MMSE showed that patients with depression and controls had a similar cognitive 
level, while the cognitive level of AD patients was significantly lower than that of the depressed and 
control participants. Independent sample t-tests showed that depressed patients performed significantly 
better than AD patients in all the neuropsychological tasks used (Table 2). When the individual scores 
were compared to published normative data (cut-off values), depressed patients’ memory performance 
(i.e., Word List and the delayed recall of the Rey Figure) and attention (TMT part B) was found to be 
below cut-off in around 50% of the patients while almost 100% of the AD patients performed below cut-
off. This suggests that although, at a group level, depressed patients were at a better cognitive level than 
AD patients, in memory and attention around half of them performed below the normality threshold. 
This would have made it difficult to distinguish which patient belonged to which group on the basis of 
these measures alone. 
Visual STM task 
A′  analysis 
Mean sensitivity data are shown in Fig. 2a. Significant main effects were found for Group 
[F(2,39) = 20.1, p < 0.001], for condition [F(1.26,49.36) = 37.74, p < 0.001], and for the interaction 
between these factors [F(2.53,49.36) = 12.2, p < 0.001].      
   Bonferroni-corrected post-hoc tests carried out on the main group effect 
showed that controls and depressed patients did not differ whereas both performed significantly better 
than AD patients (p < 0.001 in both cases). Bonferroni-corrected pairwise comparisons carried out on the 
main effect of conditions showed that performance in the condition assessing STM for shape only and 
color only did not differ and both were better than performance in the condition assessing STM for 
shape-color binding (p < 0.001 in both cases).       
   In order to assess the interaction, post-hoc tests were carried out across groups 
for each condition separately. This showed that depressed patients and controls did not differ in any of 
the experimental conditions and both groups performed significantly better than AD patients only in the 
condition assessing STM for shape-color binding (p < 0.001 in both cases). Comparisons carried out 
across conditions for each group separately showed that the performance of controls and depressed 
patients did not differ in any contrast. The performance of AD patients in the conditions assessing STM 
for shape only and color only did not differ and both were significantly better than performance in the 
condition assessing STM for shape-color binding (p = 0.001 in both cases). Therefore, these results 
suggest that the significant group by condition interaction was solely driven by the poor performance of 
AD patients in the condition assessing STM for shape-color binding. 
Beta analysis 
Figure 2b shows mean response bias (Beta) data for the three groups in the three conditions. Significant 
main effects were found for group [F(2,39) = 3.87, p < 0.05], for condition [F(2,78) = 12.45, p < 0.05], 
but not for the interaction [F(4,78) = 2.36, n.s.].      
 Bonferroni-corrected post-hoc tests carried out on the group effect showed no difference in 
response bias across the three groups. Bonferroni-corrected pairwise comparisons carried out on the 
main effect of conditions showed that STM performance in the condition assessing shape-color binding 
resulted in a greater response bias than did the condition assessing shape only (p = 0.003) and color only 
(p < 0.001). Response bias in the last two conditions did not differ. Therefore, these results suggest that a 
preference for a particular response (i.e., same or different) did not account for the poor sensitivity 
observed in AD patients. 
Classification analysis 
ROC analysis confirmed that only the task assessing the binding of information in STM combines 
sensitivity and specificity for AD (Fig. 3). ROC analysis revealed that with a cut-off value for A′ of 0.85, a 
sensitivity of 86% and a specificity of 100% for AD were achieved. This cut-off value yielded positive and 
negative predictive values of 100 and 88%, respectively. No other task used in the assessment achieved 
this classification power. Using the same cut-off value, the STM-binding task proved insensitive to MD 
(sensitivity = 14%, specificity = 93%, positive predictive values = 67%, negative predictive 
values = 54%). 
Discussion 
The results of the present study revealed that visual STM binding is impaired in late-onset sporadic AD. 
This extends previous findings of verbal STM-binding deficit in AD [67]. Taken together, the findings 
suggest that STM-binding deficits in AD are not restricted to a particular memory domain (i.e., visual or 
verbal) or to a specific retrieval process (i.e., recall or recognition), but are a fundamental impairment of 
AD. Moreover, we have found that visual STM binding discriminates between AD and MD in the elderly 
with high sensitivity.          
 It is worth noting that the results presented here were obtained using a task that firstly separates 
the contribution of item memory and memory binding to the representation of complex events in STM 
[67], and secondly has proved to be insensitive to the effects of age [8, 68]. Further evidence for the latter 
is given in the present study in which the performance of older controls was equivalent across the three 
experimental conditions. With this methodology we have demonstrated that even when AD patients’ 
performance in tasks assessing memory for individual features is equivalent to that of controls and MD 
patients, they present with paramount difficulties in retaining in STM the binding between these features. 
This suggests that STM-binding deficits are specific to AD and that these deficits are much greater than 
other memory impairments for individual items.      
 Although many of the depressed patients were impaired on a range of traditional memory tasks 
(e.g., Word List recall), they did not differ from our control group in any of the conditions used in the 
STM-binding task. The reason for this normal performance may be that the STM-binding task was based 
on a change detection paradigm that assesses recognition. There is agreement that recognition is generally 
a less demanding task than recall [40, 51, 52] and that within recognition tasks, change detection tasks are 
even less demanding [14]. The reason is that in change detection tasks the role of familiarity is crucial as 
both test and probe phases present the same items in 50% of the trials [14, 69].   
 This is relevant to the discussion of the possible effects of depression on memory performance. 
There is neuroimaging evidence suggesting that, as compared to controls, depressed patients show 
functional, but not behavioral, changes in memory processing of face-profession associations [84, 87]. 
The authors suggested that the functional changes may reflect compensatory activity responsible for 
maintaining the level of performance of depressed patients at a level equivalent to that of the control 
participants ([84] see also [11] for a review on the neuroanatomical implications of chronic depression). 
These compensatory changes, however, seem to be less efficient as the task demands increase. There is 
agreement that to achieve high sensitivity and specificity in the differential diagnosis between AD and 
MD, the tasks used should not have high cognitive demands as the performance of depressed patients 
may drop dramatically when the difficulty of the tasks increases [6, 16, 19, 20, 37]. For example, tasks 
assessing free recall (e.g., prose recall, word list recall, etc.) are poorly performed by depressed patients 
[19]. However, tasks assessing cued recall are performed by depressed patients with less difficulty [16, 79]. 
These findings have been explained by postulating that cues are used as memory aids, hence less cognitive 
effort is required (e.g., in the current change detection task features or bindings are shown at encoding 
and probe phases). However, in free recall tasks, the reliance on contextual information is higher and the 
tasks are more cognitively demanding [16]. Free recall seems to be more dependent on the hippocampus, 
a region that has been found to be impaired in middle-aged depressed patients even after their first 
episode of depression [27].         
 In fact, the compensatory changes found in the fMRI studies mentioned above were observed 
with tasks presenting face-profession pairs at encoding and faces as cues at test [84, 87]. Frodl et al. [26] 
observed increased connectivity in the prefrontal regions in depressed patients during a face-matching 
task. This suggests that brain changes occurring in the form of new compensatory connections may 
underlie normal performance of depressed patients on relatively low-demanding tasks. However, these 
types of changes are less likely to occur in AD as the main pathological outcome of the disease is loss of 
brain connectivity [32, 83, 89]. This can help to explain why AD patients are less able to bind in memory 
the different elements of complex events as accurate binding requires efficient connectivity at a 
neuroanatamocial level [82].         
 The task presented here has demonstrated that it is the binding of different pieces of information 
together rather than memory for individual features that is more severely affected by AD and which can 
differentiate AD from MD patients. As compared to LTM and attention functions, STM binding proved 
to be more successful at differentiating between AD and MD. In the condition assessing shape-color 
binding, only five out of 14 depressed patients fell below cut-off whereas in the word lists recall task, 14 
out of 14 depressed patients fell below cut-off (using 95% CI). This is in contrast with the results of the 
AD group in which 13 out of 14 and 14 out of 14 patients fell below cut-off in the shape-color binding 
condition and in the word lists recall task, respectively. These results were further supported by a 
classification analysis (using ROC methodology) which confirmed that the STM-binding task combines 
sensitivity and specificity for AD and is insensitive to MD. Notably, these results with the STM task were 
obtained when no significant differences were found in performance on conditions assessing memory for 
single features (i.e., shape or color only) across the three groups. It is worth noting that the paramount 
binding deficit observed in AD patients was not restricted to the set size chosen for the analysis presented 
here (i.e., two items). The reason for this selection was explained above. When AD patients were assessed 
with visual arrays of three items, STM for bindings was still much poorer than STM for single features 
(see Supplementary Material). This suggests that the specificity of the STM-binding deficit observed in 
AD does not reflect a general memory limitation resulting from increased memory load.  
 One other study in which a different working memory component was used to address the issue 
of the differential diagnosis between AD and depression was that by Kaschel et al. [44]. In this study, the 
authors asked AD and depressed patients to perform two concurrent tasks one of which was delivered at 
the individual span (i.e., digit span). The function of the executive component of working memory was 
measured by computing the cost of performing two concurrent tasks as compared to performing each 
task separately. The authors reported that AD patients presented with paramount difficulties performing 
two concurrent tasks whereas depressed patients’ performance was similar to that of controls. These 
previous findings and the current findings lead to the suggestion that, including working memory tasks in 
the assessment, such as the STM binding task reported here, would enable the separation of depressed 
patients from AD patients more accurately than when other more traditional tests of memory and 
attention are used. The results reported in the current study were obtained with a relatively small sample 
of AD and MD patients. Notwithstanding the specificity of the STM-binding deficit in AD was 
corroborated through ANOVA and ROC analysis. Future studies should investigate whether the results 
presented here also characterize a larger sample of patients.     
 In conclusion, STM-binding deficits may be conceived as a fundamental marker of AD. These 
impairments seem to extend across memory systems (i.e., STM and LTM), memory domains (i.e., verbal 
and visual), retrieval mechanisms (i.e., recall and recognition) and clinical forms of AD (i.e., late-onset 
sporadic AD and early onset familial AD). The present study provides novel insights in suggesting that 
AD affects the mechanisms responsible for binding information in visual STM in a significantly larger 
proportion of patients than depression. As STM-binding tasks have proved to achieve high sensitivity and 
specificity in detecting AD, they may be proposed as useful and complementary tools for the assessment 
of AD and MD in clinical settings. 
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Tables and Figures 
 
Table 1. Demographic and psychometric characteristics of participants entering the study 
 
  
Healthy controls 
(n = 14) 
Depressed 
patients (n = 14) 
AD patients 
(n = 14)   P-value 
M (SD) Range M (SD) Range M (SD) Range 
Age 70.71 (4.30) 65–79 
72.71 
(7.54) 60–82 
76.29 
(5.78) 65–84 
F (2,39) 
0.06 
3.07 
Gender 
(M/F) 07-Jul   04-Oct   07-Jul   
X 2 
(df = 2) 0.42 
1.75 
Years of 
education 
15.57 
(3.32) 10–23 
13.43 
(3.01) 9–18 
12.71 
(3.77) 8–20 
F (2,39) 
0.08 
2.71 
VIQ 107.93 (14.48) 60–118 
113.00 
(7.24) 
100–
126 
106.36 
(6.77) 94–119 
F (2,39) 
0.21 
1.64 
 One-way ANOVA. None of the Bonferroni-corrected post-hoc tests resulted in significant differences; VIQ verbal IQ as measured by Wechsler Test of Adult Reading  
Fig. 1  
 
a Shapes used to construct stimuli arrays. b Experimental conditions and trial designs  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Results of the neuropsychological assessment and the STM-binding task 
 
  Cut-off 
Healthy 
controls 
(n = 14) 
Depressed 
patients (n = 14) No. below 
cut-off 
AD patients 
(n = 14) No. below 
cut-off M 
(SD) Range M (SD) Range M (SD) Range 
MMSEa 24 28.83 (1.47) 26–30 
28.21 
(1.37) 25–30 0 
23.36 
(2.73) 17–27 10 
ACEb 84d     90.93 (5.38) 82–99 2 
64.64 
(11.71) 40–79 14 
Word list I 
(recall)b 29
c     6.93 (3.41) 0–11 14 
0.79 
(1.81) 0–5 14 
Word list II 
(recognition)b 23
c     22.00 (1.92) 19–24 7 
14.36 
(3.03) 7–18 14 
Letter fluency 
(FAS)b 22
d     42.21 (10.56) 24–59 0 
24.86 
(12.11) 8–50 8 
Verbal fluency 
(animals)b 12.1
d     17.79 (4.10) 9–24 1 
9.07 
(4.91) 2–18 10 
TMT part Ab 57.6d     47.86 (16.87) 28–83 4 
138.42 
(139.36) 28–502 11 
TMT part Bb 145d     129.50 (48.30) 52–213 6 
305.00 
(164.60) 87–732 13 
Rey figure 
(copy)b 31
c     34.52 (1.83) 30–36 1 
26.89 
(11.74) 4–36 5 
Rey figure 
(delayed 
recall)b 
13c     11.43 (8.94) 0–27 9 
3.18 
(4.79) 0–13 13 
Shape only 
(A′) 0.95
e         3     6 
Color only (A′) 0.98e         6     8 
Shape-color 
binding (A′) 0.91
e         5     13 
 
aAD patients different from controls and depressed patients at p < 0.05 (one-way ANOVA—post-hoc 
tests) 
bDepressed and AD patients different at p < 0.05 (Independent sample t tests) 
c5th percentile taken from standardized age-matched normative data 
dMean and SD taken from standardized age-matched normative data 
eLower bound of the CI at 95% calculated from controls; MMSE Minimental State Examination; M (SD) 
mean and standard deviation; norms from: ACE [54]; word list [85]; letter fluency (FAS) [78]; verbal 
fluency (animals) [81]; TMT [80]; Rey Figure [21] 
Fig. 2.  
a Mean sensitivity data (A′) and (b) mean response bias in the group by condition analysis (Error bars 
represent the standard errors of the mean) 
 
 
 
 
 
 
 
 
Fig. 3. ROC analysis with the three conditions of the visual STM task in (a) AD and (b) MD patients 
 
 
 
 
